International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature

Pharmacological Reviews

Volumn 54, Issue 2, 2002, Pages 219-226

  Davenport, Anthony P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; 4 (1,3 BENZODIOXOL 5 YL) 1 [(2,6 DIETHYLPHENYL)CARBAMOYLMETHYL] 2 (4 PROPOXYPHENYL) 3 PYRROLIDINECARBOXYLIC ACID; 4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID; 5 DIMETHYLAMINO N (3,4 DIMETHYL 5 ISOXAZOLYL) 1 NAPHTHALENESULFONAMIDE; ALPHA [[1 BUTYL 5 [2 [(2 CARBOXYPHENYL)METHOXY] 4 METHOXYPHENYL] 1H PYRAZOL 4 YL]METHYLENE] 6 METHOXY 1,3 BENZODIOXOLE 5 PROPANOIC ACID; ATRASENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DARUSENTAN; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR 1; ENDOTHELIN RECEPTOR 2; ENDOTHELIN RECEPTOR 3; IODINE 125; L 1620; L 754142; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N (HEXAHYDRO 1 AZEPINYLCARBONYL)LEUCYL(1 METHYL DEXTRO TRYPTOPHYL) DEXTRO TYROSINE; N ACETYLENDOTHELIN 1 [6-21][11,15 ALANINE]; PD 164333; RADIOLIGAND; SARAFOTOXIN S6C; SITAXSENTAN; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE]; TRITIUM; UNCLASSIFIED DRUG;

DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; MOLECULAR CLONING; NOMENCLATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RECEPTOR BLOCKING; RECEPTOR SENSITIVITY; REVIEW; VASOCONSTRICTION;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; INTERNATIONAL AGENCIES; MOLECULAR SEQUENCE DATA; RECEPTORS, ENDOTHELIN; TERMINOLOGY;

EID: 0036266042     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: 10.1124/pr.54.2.219     Document Type: Review

References (74)

1. Cloning and characterization of cDNA encoding human A-type endothelin receptor
2. Cloning and expression of a cDNA encoding an endothelin receptor
3. Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells
4. Characterization of a potent and selective endothelin-B receptor antagonist, IRL 2500
5. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons
6. Endothelin-1 and ETA receptor expression in vascular smooth muscle cells from human placenta: A new ETA receptor messenger ribonucleic acid is generated by alternative splicing of exon 3
7. Alternative transcript of the nonselective-type endothelin receptor from rat brain
8. Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice
9. B receptor antagonist Ro 46-8443
10. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist
11. Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use
12. Distribution of endothelin receptors
13. Endothelin receptors
14. A selective non-peptide radiolabelled antagonist, in normal and diseased human tissues
15. A receptors
16. 125I ET-1, ET-2, ET-3 and vasoactive intestinal contractor are present in adult rat brain and neuroneenriched primary cultures of embryonic brain cells
17. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endotheliumderived relaxing factor
18. A receptor)-selective antagonists
19. Pharmacologic evidence for the presence of three functional endothelin receptor subtypes in rabbit saphenous vein
20. 1,3-Diarylindan-2-carboxylic acids, potent and selective non-peptide endothelin receptor antagonists
21. Molecular characterization of a novel human endothelin receptor splice variant
22. Molecular cloning and characterization of the major endothelin receptor subtype in porcine cerebellum
23. Endothelin B receptors on human endothelial and smooth-muscle cells show equivalent binding pharmacology
24. Endothelin B receptor modulates inflammatory pain and cutaneous inflammation
25. Contribution of endogenous generation of endothelin-1 to basal vascular tone
26. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice
27. Cloning and expression of human endothelin-1 receptor cDNA
28. Biological profiles of highly potent novel endothelin antagonists selective for the ET(A) receptor
29. B) receptors
30. A receptor subtype
31. The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes
32. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788
33. Purification and characterization of bovine lung endothelin receptor
34. Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor
35. A receptors mediate the constrictor responses to endothelin peptides in human blood vessels in vitro
36. A receptor antagonist, determined for human endothelin receptors
37. Failure of BQ123, a more potent antagonist of sarafotoxin S6b than of endothelin-1, to distinguish between these agonists in binding experiments
38. International Union of Pharmacology nomenclature of endothelin receptors
39. Endothelin family peptides in human plasma and urine: Their molecular forms and concentrations
40. Alternative RNA splicing of the human endothelin-A receptor generates multiple transcripts
41. Analysis of two pharmacologically predicted endothelin B receptor subtypes by using the endothelin B receptor gene knockout mouse
42. 1,3,11,15]ET-1 in human heart
43. A receptor antagonist inhibits neointima formation induced endothelial injury
44. Cloning and sequence analysis of a cDNA encoding human non-selective type of endothelin receptor
45. Characterization of a novel porcine endothelin(B) receptor splice variant
46. A receptors in endothelial cells in situ on the aortic side of porcine aortic valve
47. A receptor antagonist
48. Nonpeptide endothelin receptor antagonists. VI. Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist
49. A-selective receptor antagonist
50. Characterization of endothelin receptor selective agonist BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart
51. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease
52. Receptor selectivity of endothelin antagonists and prevention of vasoconstriction and endothelin-induced sudden death
53. B selective ligands in human and rat heart
54. Human endothelial cell storage granules: A novel intracellular site for isoforms of the endothelin converting enzyme
55. B agonistic activity
56. B receptor and identification of signal peptidase and metal proteinase cleavage sites
57. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
58. Two distinct human endothelin B receptors generated by alternative splicing from a single gene
59. A antagonist 5-(dimethy]amino)-N-(3,4-dimethyl-5- isoxazo]yl)- 1-naphthalenesulfonamide
60. B receptor
61. Sarafotoxins S6, several isotoxins from Atractaspis engaddensis (burrowing asp) venom that affect the heart
62. Novel mutations of the endothelin B receptor gene in patients with Hirschsprung's disease and their characterization
63. RES-701-1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin
64. An endothelin B receptor-selective antagonist: IRL 1038, [Cys11-Cys15]-endothelin-1(11-21)
65. B selectivity
66. Comparative studies with the endothelin receptor antagonists BQ-123 and PD142893 indicate at least three endothelin receptors
67. Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat
68. 125I]IRL1620
69. Sarafotoxin S6c, an agonist which distinguishes between endothelin receptor subtypes
70. Pharmacology of L-754,142, a highly potent, orally active, nonpeptidyl endothelin antagonist
71. Discovery of TBC11251, a potent, long acting, orally active endothe]in receptor-A selective antagonist
72. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
73. A dinucleotide mutation in the endothelin-B receptor gene is associated with lethal white foal syndrome (LWFS), a horse variant of Hirschsprung disease
74. Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma